Omicron variant: Move over, Delta
-
wrote on 28 Nov 2021, 21:08 last edited by
-
wrote on 28 Nov 2021, 21:10 last edited by
Very clever.
-
wrote on 28 Nov 2021, 21:11 last edited by
@jolly said in Move over, Delta:
Shocking...
Jolly, he is way off base. Novavax received emergency authorization for itās regular vaccine. They are now starting to research and develop an Omicron vaccine update. Moderna, J&J and the others are now talking about testing their standard vaccine against the variant, which makes sense.
-
wrote on 28 Nov 2021, 21:43 last edited by
The Bee just keeps doing that thing it does
-
wrote on 28 Nov 2021, 21:45 last edited by
-
wrote on 29 Nov 2021, 12:07 last edited by
@george-k said in Move over, Delta:
The "already worried" tweet was on Aug 4.
Hey, I'm still holding out hope for my Omega Variant prediction from Aug 2: https://nodebb.the-new-coffee-room.club/topic/10582/what-s-the-next-best-outbreak-name
-
wrote on 29 Nov 2021, 21:11 last edited by
-
You completely miss the point in true Axian manner. No one said Trump's bans were great or effective. But Biden slammed them as racist and now imposes his own.
wrote on 30 Nov 2021, 14:40 last edited by@mik said in Move over, Delta:
You completely miss the point in true Axian manner. No one said Trump's bans were great or effective. But Biden slammed them as racist and now imposes his own.
-
wrote on 30 Nov 2021, 14:44 last edited by
This is how the man was treated. Then they want to talk about uniting the country and what is best for the US. Shameless.
-
wrote on 30 Nov 2021, 18:05 last edited by
Moderna CEO expects material drop in Moderna vaccineās effectiveness against the Omicron variant.
-
Moderna CEO expects material drop in Moderna vaccineās effectiveness against the Omicron variant.
wrote on 30 Nov 2021, 18:15 last edited by@axtremus said in Move over, Delta:
Moderna CEO expects material drop in Moderna vaccineās effectiveness against the Omicron variant.
At this point in time, he's blowing smoke out of his ass.
-
Moderna CEO expects material drop in Moderna vaccineās effectiveness against the Omicron variant.
wrote on 30 Nov 2021, 18:16 last edited byThis post is deleted! -
wrote on 30 Nov 2021, 18:51 last edited by
-
wrote on 30 Nov 2021, 18:56 last edited by
@George-K Reminds me of @bachophile post about spread vs seriousness of diseaseā¦ This may be less serious on average, but if itās spread is wider it could be far worse than Delta.
-
wrote on 30 Nov 2021, 18:58 last edited by
@Jolly I would think that they could look at the particular spike proteins their particular vaccine targets and be able to say āoh
ā -
wrote on 30 Nov 2021, 19:19 last edited by
If we weren't fed a line of crap, the vaccines should work fairly well against most variants, since about 95% have proteins the vaxx will recognize.
-
wrote on 1 Dec 2021, 17:25 last edited by jon-nyc 12 Jan 2021, 17:25
Dr. UÄur Åahināthe co-founder of BioNTech who helped develop Pfizerās mRNA COVID-19 vaccineātold The Wall Street Journal Tuesday that, even if the Omicron variant leads to more breakthrough COVID-19 infections, he believes the vaccines will continue to protect against severe disease. āIf a virus achieves immune escape, it achieves it against antibodies, but there is the second level of immune response that protects from severe diseaseāthe T-cells,ā he said.
The European Centre for Disease Prevention and Control said yesterday that as of Tuesday morning, 44 Omicron variant cases had been confirmed by 11 European countries and that āall cases for which there is information available on severity were either asymptomatic or had mild symptoms.ā
-
Dr. UÄur Åahināthe co-founder of BioNTech who helped develop Pfizerās mRNA COVID-19 vaccineātold The Wall Street Journal Tuesday that, even if the Omicron variant leads to more breakthrough COVID-19 infections, he believes the vaccines will continue to protect against severe disease. āIf a virus achieves immune escape, it achieves it against antibodies, but there is the second level of immune response that protects from severe diseaseāthe T-cells,ā he said.
The European Centre for Disease Prevention and Control said yesterday that as of Tuesday morning, 44 Omicron variant cases had been confirmed by 11 European countries and that āall cases for which there is information available on severity were either asymptomatic or had mild symptoms.ā
wrote on 1 Dec 2021, 19:00 last edited by@jon-nyc said in Move over, Delta:
Dr. UÄur Åahināthe co-founder of BioNTech who helped develop Pfizerās mRNA COVID-19 vaccineātold The Wall Street Journal Tuesday that, even if the Omicron variant leads to more breakthrough COVID-19 infections, he believes the vaccines will continue to protect against severe disease. āIf a virus achieves immune escape, it achieves it against antibodies, but there is the second level of immune response that protects from severe diseaseāthe T-cells,ā he said.
IOW, he believes the Nu variant of Wuhan COVID -Xi 19 achieves immune escape against the current virus but they are hoping that the T-Cells will save the day. The question I have is if the T-Cells are working on the same recognition patterns as the antibodies, why do they think it will work? The ID of the spike proteins had to be very specific as there are necessary and beneficial spike proteins that you do not want to mess with. Itās a big part of the concern with the Merck pill. They have seen examples of stillborn and birth defects when administered to pregnant animals.
https://www.latimes.com/science/story/2021-11-29/fda-merck-covid-pill-effective-but-flags-safety-concerns-pregnant-women -
wrote on 1 Dec 2021, 19:00 last edited by
@jon-nyc said in Move over, Delta:
The European Centre for Disease Prevention and Control said yesterday that as of Tuesday morning, 44 Omicron variant cases had been confirmed by 11 European countries and that āall cases for which there is information available on severity were either asymptomatic or had mild symptoms.ā
That would be the same number with Delta or even Alpha.